HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Colin Pawlowski Selected Research

Colin Pawlowski Research Topics

Disease

13COVID-19
07/2022 - 01/2021
5Infections
12/2022 - 01/2020
2Breakthrough Infections
07/2022 - 05/2022
2Intracranial Sinus Thrombosis (Sinus Thrombosis)
01/2022 - 10/2021
2Acute Kidney Injury (Acute Renal Failure)
07/2021 - 03/2021
1Post-Acute COVID-19 Syndrome
12/2022
1Pericarditis
01/2022
1Anaphylaxis (Anaphylactic Shock)
01/2022
1Myocarditis (Carditis)
01/2022
1Anemia
07/2021
1Septic Shock (Toxic Shock Syndrome)
07/2021
1Dizziness (Lightheadedness)
05/2021
1Fever (Fevers)
05/2021
1Nausea
05/2021
1Myalgia
01/2021
1Measles
01/2021
1Poliomyelitis (Polio)
01/2021
1Hepatitis B
01/2021
1Rubella (German Measles)
01/2021
1Hepatitis A (Hepatitis, Infectious)
01/2021
1Headache (Headaches)
01/2021
1Chickenpox
01/2021
1Mumps
01/2021
1Fatigue
01/2021
1Thromboembolism
01/2020

Drug/Important Bio-Agent (IBA)

10VaccinesIBA
07/2022 - 01/2021
4BNT162 VaccineIBA
07/2022 - 01/2021
42019-nCoV Vaccine mRNA-1273IBA
05/2022 - 01/2021
3COVID-19 VaccinesIBA
07/2022 - 10/2021
2mRNA VaccinesIBA
01/2022 - 01/2021
2Enoxaparin (Lovenox)FDA LinkGeneric
07/2021 - 03/2021
2Heparin (Liquaemin)FDA LinkGeneric
07/2021 - 03/2021
2AnticoagulantsIBA
07/2021 - 03/2021
1HDL CholesterolIBA
12/2022
1Triglycerides (Triacylglycerol)IBA
12/2022
1insulin receptor-related receptor (IRR)IBA
05/2022
1Messenger RNA (mRNA)IBA
01/2022
1Ad26COVS1IBA
11/2021
1casirivimab and imdevimab drug combinationIBA
10/2021
1bamlanivimabIBA
05/2021
1gamma- hydroxy- gamma- ethyl- gamma- phenylbutyramide (HEPB)IBA
01/2021
1Fibrinogen (Factor I)FDA Link
01/2020
1Dacarbazine (DIC)FDA LinkGeneric
01/2020

Therapy/Procedure

1Therapeutics
07/2021